The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Smith Rachel since 2018.
The trader's CIK number is 1593089.
At the time of the last reporting, Smith Rachel was the Vice President of R&D of Capricor Therapeutics, Inc.. (stock ticker symbol CAPR).
Also see all insider trading activities at Capricor Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | CAPR | 0 | $0 | 0 | $0 | 20,748 | $3,319 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-22 | CAPR | Option Ex | 20,748 | .16 | 3,319 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Rachel (Vice President of R&D of Capricor Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.